Biotech Distilled
| Platform |  | Pricing | Freemium | Publishes | Daily |
|---|---|---|---|---|---|
| Issues | 575 | Founded | 6 months ago | Last Issue | 4 days ago |
| Active | |||||
Read this Newsletter
biotechdistilled.substack.comLatest Issues
UPDATE: Immunovant (IMVT) - The Bio-Better Bet Cashes Its First Check
The D2T RA Print Lands, and the Thesis Tightens
This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.
UPDATE: ImmunityBio (IBRX) - The Papillary Loop Officially Closes
This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.
One year and one day after the May 2025 Refuse to File letter, the FDA has accepted ImmunityBio’s resubmitted supplem...
Cue Biopharma, Inc. (CUE) — Scientific Deep Dive for CUE-221 and Pipeline Products
Out-Xolair-ing Xolair: How a CD23-Engaging Anti-IgE Could Disrupt a $1.7B Allergy Franchise
This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.
UPDATE: Medicenna Therapeutics (MDNAF) - The Pricing Print Lands, and the Tape Tells You Everything
The offering terms are finalized. The PR doesn’t disclose the discount. The stock does — down 28.5% in four sessions.
This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.
UPDATE: ImmunityBio (IBRX) - AUA 2026 Lands the Competitive Receipts on Nadofaragene and TAR-200
Two indirect treatment comparisons at urology’s biggest meeting suggest NAI+BCG doubles duration of response vs. Ferring’s Adstiladrin and cuts adverse events 68% vs. J&J’s TAR-200.
This Substack is reader-supported. To receive new posts a...
Audience Metrics
Subscribers, engagement, traffic and sponsorship for Biotech Distilled.
| Subscribers | Engagement | 78 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Chart Rankings
How this newsletter ranks in the official Substack charts.
| #80 |
Authors
The writers behind this newsletter.
PhD in Medicinal Chemistry. Senior Patent Agent. Extensive experience evaluating drug discovery programs — from molecular mechanism to clinical plausibility.
Frequently Asked Questions
How can I access the email archive for Biotech Distilled?
You can find recent issues that have been published by Biotech Distilled on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Biotech Distilled have?
To see how many people subscribe to Biotech Distilled, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Biotech Distilled?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Biotech Distilled as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Biotech Distilled?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Biotech Distilled using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to Biotech Distilled?
Scroll up to where it says Related Newsletters to see other publications like Biotech Distilled. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Biotech Distilled?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.